Loading...
New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
Clinical outcome remains poor in high-risk neuroblastoma patients, where chemoresistant relapse is common following high-intensity conventional multimodal therapy. Novel treatment approaches are required. Although recent genomic profiling initiatives have not revealed a high frequency of mutations i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3818140/ https://ncbi.nlm.nih.gov/pubmed/23965898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0680 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|